EKF Diagnostics Holdings plc (AIM:EKF)
London
· Delayed Price · Currency is GBP · Price in GBX 21.48
+0.28 (1.30%)
Mar 28, 2025, 10:19 AM GMT+1
EKF Diagnostics Holdings Revenue
In the year 2024, EKF Diagnostics Holdings had annual revenue of 50.19M GBP, down -4.59%. EKF Diagnostics Holdings had revenue of 24.98M in the half year ending December 31, 2024, a decrease of -14.34%.
Revenue
50.19M
Revenue Growth
-4.59%
P/S Ratio
1.91
Revenue / Employee
162.44K
Employees
317
Market Cap
95.74M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 50.19M | -2.42M | -4.59% |
| Dec 31, 2023 | 52.61M | -14.02M | -21.05% |
| Dec 31, 2022 | 66.64M | -15.20M | -18.57% |
| Dec 31, 2021 | 81.84M | 16.58M | 25.40% |
| Dec 31, 2020 | 65.26M | 20.34M | 45.29% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AstraZeneca | 43.19B |
| GSK plc | 31.38B |
| Haleon | 11.23B |
| Smith & Nephew | 4.64B |
| ConvaTec Group | 1.83B |
| Hikma Pharmaceuticals | 2.50B |
| HUTCHMED (China) | 503.39M |
| Genus | 671.60M |